Industry News
Discovery Of Genetic Link To Prostate Cancer Risk In African Americans
Sep 04, 2012
Prostate cancer in African-American men is associated with specific changes in the IL-16 gene, according to researchers at the University of Illinois at Chicago College of Medicine. The study, published online in the journal Cancer Epidemiology, Biomarkers & Prevention, establishes the association of IL-16 with prostate cancer in men of both African and European descent... Read More
New Approach Reduces Central Line Infections Among Kids With Cancer
Sep 04, 2012
According to a study conducted by Johns Hopkins researchers and published in Pediatrics, experts have developed a 'triple-threat' method for reducing risky infections in the central line in pediatric cancer patients... Read More
Following Orthopaedic Surgery Or Trauma, Anti-Clotting Therapy May Be Used Too Often
Sep 04, 2012
Some smaller clots may not require potentially risky treatment Men and women who undergo joint replacement procedures, as well as those who have significant fractures, tend to be at an increased risk of developing pulmonary emboli (PE), blood clots that travel to the lungs where they may cause serious complications and even death... Read More
Following Orthopaedic Surgery Or Trauma, Anti-Clotting Therapy May Be Used Too Often
Sep 04, 2012
Some smaller clots may not require potentially risky treatment Men and women who undergo joint replacement procedures, as well as those who have significant fractures, tend to be at an increased risk of developing pulmonary emboli (PE), blood clots that travel to the lungs where they may cause serious complications and even death... Read More
New Intriguing Knowledge On Blood Haemoglobin Published
Sep 04, 2012
Scientists at the research centre MEMBRANES at Aarhus University, Denmark, have completed an old puzzle, which has been regarded as impossible to complete since the 60s. The challenge was to solve the structure of the protecting protein complex that forms when haemoglobin is released from red cells and becomes toxic... Read More
New Intriguing Knowledge On Blood Haemoglobin Published
Sep 04, 2012
Scientists at the research centre MEMBRANES at Aarhus University, Denmark, have completed an old puzzle, which has been regarded as impossible to complete since the 60s. The challenge was to solve the structure of the protecting protein complex that forms when haemoglobin is released from red cells and becomes toxic... Read More
Xtandi (Enzalutamide) Approved For Late Stage Prostate Cancer, FDA
Sep 03, 2012
Xtandi (enzalutamide) has been approved for men with metastatic castration-resistant prostate cancer that has recurred or spread, regardless of whether patients received medical or surgical therapy to reduce testosterone levels, the US Food and Drug Administration (FDA) announced. Enzalutamide has been approved to be administered alongside docetaxel, another cancer medication... Read More
DEAD-Box Proteins Function As Recycling Nanopistons When Unwinding RNA
Sep 03, 2012
Molecular biologists at The University of Texas at Austin have solved one of the mysteries of how double-stranded RNA is remodeled inside cells in both their normal and disease states. The discovery may have implications for treating cancer and viruses in humans... Read More
Combined Chemotherapy Effective For Immunodeficient Patients With Secondary Lung Disease
Sep 03, 2012
A team of researchers at the Medical College of Wisconsin and Children's Hospital of Wisconsin Research Institute defined a new treatment for a potentially fatal lung disease in patients with a primary immunodeficiency known as common variable immunodeficiency (CVID).The findings are published in the Journal of Clinical Immunology... Read More
Combined Chemotherapy Effective For Immunodeficient Patients With Secondary Lung Disease
Sep 03, 2012
A team of researchers at the Medical College of Wisconsin and Children's Hospital of Wisconsin Research Institute defined a new treatment for a potentially fatal lung disease in patients with a primary immunodeficiency known as common variable immunodeficiency (CVID).The findings are published in the Journal of Clinical Immunology... Read More
Previous Page Next Page